The EUnetHTA Joint Action 2 Grant Agreement has been signed by the EU Executive Agency for Health and Consumers and the Coordinator (Danish Health and Medicines Authority) on behalf of 37 partners in 26 EU Member States, Croatia and Norway to start its activities on October 1, 2012.
The European Commission launched stakeholder consultation on modalities of stakeholder involvement in the future voluntary HTA network (Directive 2011/24/EU).
EUnetHTA is conducting a pilot by WP5, Relative Effectiveness Assessment (REA) of Pharmaceuticals, in which the draft tools that are being developed for relative effectiveness assessment of pharmaceuticals are tested.
An article on SCRIPT about HTA and EUnetHTA